sym-trinitrobenzene has been researched along with transforming growth factor beta in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Majewska-Szczepanik, M; Marcińska, K; Strzepa, A; Szczepanik, M; Wen, L | 1 |
1 other study(ies) available for sym-trinitrobenzene and transforming growth factor beta
Article | Year |
---|---|
Epicutaneous immunization with TNP-Ig and Zymosan induces TCRαβ+ CD4+ contrasuppressor cells that reverse skin-induced suppression via IL-17A.
Topics: Administration, Cutaneous; Animals; Antigens; CD4-Positive T-Lymphocytes; Dermatitis, Contact; Haptens; Immunity, Innate; Immunization; Immunoglobulins; Immunosuppression Therapy; Interleukin-17; Lymph Nodes; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Myeloid Differentiation Factor 88; Receptors, Antigen, T-Cell, alpha-beta; Skin; Toll-Like Receptor 2; Transforming Growth Factor beta; Trinitrobenzenes; Vaccination; Zymosan | 2014 |